Beacon Angels 2018 Meeting Archive

December 11, 2018

Funding Presenters:

  • Invitrometrix, which has developed and is selling devices to life science research and drug discovery companies that uniquely provide continuous, real-time, quantitative monitoring of cells in culture, and
  • Walch High School Math, which automates the development and deployment of high school curricula, giving school districts a virtual curriculum department in the cloud.

Member Due Diligence Reports:

  • Datarista, which offers a data platform for the Sales & Marketing data industry; and
  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system for the on-site diagnosis of antibiotic-resistant infections in hospitals.

November 13, 2018

Funding Presentations:

  • First Light Biosciences, which has developed and will be bringing to market a self-contained benchtop system to diagnose antibiotic-resistant infections in hospitals; and
  • Enviro Power, which has developed the SmartWatt™ Boiler, a 95% efficient, closed-loop micro steam turbine for heating systems in homes and businesses to generate electric power on-site both as a backup and more cheaply than grid-supplied power.

Members’ due diligence reports and company updates:

  • Datarista, a platform in the third-party Sales & Marketing data industry for data providers to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua; and
  • Concrete Sensors, which is selling a system for building professionals to monitor and control the concrete curing process.

October 9, 2018

Funding Presentations:

  • Omega Trace, which is offering a product suite for brick and mortar businesses to monitor and track visitors to their premises, and
  • Weft-Tex, which has developed and is selling a proprietary breath-through crib mattress.

Member updates and due diligence reports:

  • Datarista, and
  • Zippity Cars.

September 11, 2018

Funding Presentations:

  • QMedic, which offers a smart emergency help button service partnered with health insurers to support high-risk members living at home; and
  • Datarista, a platform for data providers in the third-party Sales & Marketing data industry to create and manage integrations in CRM and Marketing Automation platforms such as Salesforce, Marketo & Eloqua.

Member reports:

  • Beacon’s participation in any extension of the Zippity round; and
  • Update on the pending bridge round by Siamab Therapeutics.

July 10, 2018

Funding Presentations:

  • Waec, which provides a low-cost, efficient local delivery option for consumers and stores using autonomous ground drones that politely navigate sidewalks and crosswalks, and
  • Mobile Price Card is which offers a patent-pending technology to help consumer electronics retailers improve sales by advertising on the screens of devices already on display.

June 12, 2018

Funding Presentations:

  • LASO Technologies, which is selling a very waterproof Iphone case and is developing other field-use Iphone accessories; and
  • ENTERAstim, which is developing a therapeutic system to stimulate the small bowel in the human GI tract electrically and speed the return of its motility from ileus to normal.

We also heard:

  • A due diligence report on Zippity Cars
  • A due diligence report on ScholarJet, and
  • An update from the CEO and founder of portfolio company Ecare Vault.

Finally, we conducted a full review of the health and prospects of the companies in the Beacon Angels portfolio.

May 8, 2018

Funding Presentations:

  • Zippity Cars, which offers maintenance services directly to car owners at their place of business,
  • BioTrak Therapeutics, which offers a mobile behavioral health app for the 2.4 billion people worldwide who suffer from frequently recurring tension-type headaches & migraines, and
  • ScholarJet, where students earn college scholarships and companies reach a talented pool of college students, vet candidates for internships and employment, and enhance their employer brand.

We heard an update on Meenta, a prior Beacon presenter.

April 10, 2018

Funding Presentation:

  • Rockstep Solutions, which offers Climb, a scalable SaaS animal laboratory informatics software product that is designed in the Azure™ Cloud to leverage smart-lab technologies and utilize more elastic resources.

The meeting featured a due diligence update on Tӧst, and Beacon hosted funding updates by the CEOs of:

  • Pykus Therapeutics, and
  • Spiro Technologies.

March 13, 2018

Funding Presentations:

  • GoPetie, a B2B & B2C mobile platform that connects pet owners to each other, to local service providers and municipalities in a social community environment, and
  • GuruSnaps, which connects business owners with professionals (Gurus) who can help them sell their business on the best terms.

Our meeting also included members’ due diligence reports on recent presenters Töst and Jobletics.

February 13, 2018

Funding Presentations:

  • Jobletics, an on-demand temp staffing marketplace for the food service and hospitality industry, and
  • Name Net Worth, which offers an app to convert your networking activity into sales opportunities.

We also entertained members’ due diligence reports on:

  • Magurobotics, and
  • Töst Beverages.
January 9, 2018
Funding Presentations:
  • Meenta which helps scientists more fully access costly and limited laboratory resources by finding, accessing and sending biological samples to idle equipment via the Cloud; and
  • Tӧst Beverages, which develops and sells uniquely delicious non-alcoholic celebratory beverages.
Posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations, Uncategorized | Tagged , , ,

Massachusetts Rated No. 1 for Innovation

WalletHub recently listed Massachusetts as first among all 50 of the United States for its potential to foster innovation, as well as the state with the number three healthiest economy overall for 2019.

Beacon Angels is pleased to be a contributor to that potential through its ongoing support of the many Massachusetts and New England based companies in its portfolio, and by continuing to invest in new startup companies here and throughout New England.

Posted in Uncategorized | Tagged

U-Chu Biosciences & KingsCrowd

At their meeting on Tuesday, June 11, 2019, Beacon members will entertain presentations for new funding from the following companies:

  • U-Chu Biosensors, which is developing real-time oral health sensors for critical care; and
  • KingsCrowd, which is offering a ratings and analytics solution for online private equity markets.  

Finally, Enviro Power, a past presenter offering a micro-power generation solution, will return to Beacon for a update on new progress and its current funding round.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Private Equity, Uncategorized

Southie Autonomy & CloudKPI

At their meeting on Tuesday, May 14, 2019, Beacon members entertained presentations from the following companies:

  • Southie Autonomy, which is developing software to program robotic arms on the fly; and
  • CloudKPI, which offers predictive analytics for SaaS businesses to use business data to identify what delivers positive or negative outcomes.  

Members also delivered a due diligence report on Shareity.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings, Uncategorized

Hilltop Biosciences & Shareity

At their meeting on Tuesday, April 9, 2019, Beacon members entertained presentations from the following companies:

  • Hilltop Biosciences, which develops and sells therapies for wound healing to large animal veterinarians; and 
    Shareity, which offers a patented social engagement platform to enable brands to create photo and video challenges whereby brands can donate money to causes as users complete the challenges. 

Members also delivered due diligence reports on Xeno Biosciences and Canary.

Beacon portfolio company Cognoptix delivered an update on its upcoming bridge round to a larger financing, whereby the valuation is hoped to represent at least a 10X increase over Beacon’s original investment over 10 years ago.

Posted in Beacon Angels Events, Beacon Events, Boston angel investing, Funding Presentations

Cricduel and Canary

Beacon Angels heard members’ due diligence reports on Wevoand Xeno Biosciences, and entertained the following new funding proposals:

  • Cricduel, a fantasy cricket app (i.e. Draftkings, but for cricket) where users create fantasy cricket teams and compete with other users for cash prizes; and 
  • Canary, offering the services of an Airbnb, but for performing artists (bands and musicians) and venues such as restaurants and bars. 

Posted in Beacon Events, Boston angel investing, Boston Startups, Funding Presentations, Past Beacon Meetings, Uncategorized

WEVO & Xeno Biosciences

At its meeting on Tuesday, February 12, 2019, Beacon Angels entertained funding proposals from: 

  • WEVO, a company that enables marketers to evaluate and enhance digital experiences without the need for live traffic, disrupting the traditional market research and AB testing tools. and
  • Xeno Biosciences, which has a disruptive approach to treating obesity that mimics the highly successful treatment of gastric bypass surgery using a simple enteric-coated pill composed of components that have been shown to be safe in man. It induces the same microbiome changes caused by the surgery resulting in weight loss.

We also entertained members’ portfolio updates and a presentation on The Capital Network.

Posted in Beacon Angels Events, Funding Presentations, Uncategorized | Tagged , ,

Neurohydrate & Theromics

Beacon Angels entertained funding proposals from the following companies at its meeting on Tuesday, January 8, 2019:

  • Neurohydrate which offers a nutritional supplement to help migraine sufferers mitigate the gastrointestinal side effects of treatments, and
  • Theromics, which offers a platform for surgeons and oncologists to thermally ablate cancerous tumors, potentially cutting recurrence from an average of 30% to zero.

Beacon also heard portfolio company updates and members’ due diligence reports on potential new investments.

Posted in Beacon Angels Events, Boston angel investing, Boston Startups, Funding Presentations, Private Equity, Uncategorized